Short-course radiation plus temozolomide in elderly patients with glioblastoma

Glioblastoma is a fatal illness that is associated with a median survival of less than 2 years. Population studies of glioblastoma have shown that survival declines with increasing age,1,2 and the incidence of glioblastoma is increasing, especially among the elderly.3 Older patients have been underr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Perry, James R. (VerfasserIn) , Wick, Antje (VerfasserIn) , Wick, Wolfgang (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: March 16, 2017
In: The New England journal of medicine
Year: 2017, Jahrgang: 376, Heft: 11, Pages: 1027-1037
ISSN:1533-4406
DOI:10.1056/NEJMoa1611977
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1056/NEJMoa1611977
Verlag, Volltext: https://doi.org/10.1056/NEJMoa1611977
Volltext
Verfasserangaben:James R. Perry, Normand Laperriere, Christopher J. O’Callaghan, Alba A. Brandes, Johan Menten, Claire Phillips, Michael Fay, Ryo Nishikawa, J. Gregory Cairncross, Wilson Roa, David Osoba, John P. Rossiter, Arjun Sahgal, Hal Hirte, Florence Laigle-Donadey, Enrico Franceschi, Olivier Chinot, Vassilis Golfinopoulos, Laura Fariselli, Antje Wick, Loic Feuvret, Michael Back, Michael Tills, Chad Winch, Brigitta G. Baumert, Wolfgang Wick, Keyue Ding, and Warren P. Mason
Beschreibung
Zusammenfassung:Glioblastoma is a fatal illness that is associated with a median survival of less than 2 years. Population studies of glioblastoma have shown that survival declines with increasing age,1,2 and the incidence of glioblastoma is increasing, especially among the elderly.3 Older patients have been underrepresented in most randomized trials, in which the average age of participants is approximately 55 years, as compared with the population-based median for patients with glioblastoma of 65 years of age.2 In 2005, a phase 3 trial of radiotherapy alone (60 Gy over a period of 6 weeks) versus radiotherapy plus temozolomide showed longer survival . . .
Beschreibung:Gesehen am 19.07.2018
Beschreibung:Online Resource
ISSN:1533-4406
DOI:10.1056/NEJMoa1611977